Department of Biomedical Engineering, Technion-Israel Institute of Technology, 32000 Haifa, Israel.
Small. 2013 Nov 25;9(22):3771-7. doi: 10.1002/smll.201300696. Epub 2013 Jun 21.
Redirecting the immune system to eliminate tumor cells is a promising alternative to traditional cancer therapies, most often requiring direct interaction between an immune system effector cell and its target. Herein, a novel approach for selective attachment of malignant cells to antigen-presenting cells by using bispecific nanoparticles is presented. The engaged cell pairs are then irradiated by a sequence of resonant femtosecond pulses, which results in widespread cell fusion and the consequent formation of hybrid cells. The dual role of gold nanoparticles as conjugating agents and fusion promoters offers a simple yet effective means for specific fusion between different cells. This technology could be useful for a variety of in vitro and in vivo applications that call for selective fusion between cells within a large heterogenic cell population.
将免疫系统重新导向以消除肿瘤细胞是一种有前途的替代传统癌症疗法的方法,通常需要免疫系统效应细胞与其靶标之间的直接相互作用。在此,提出了一种通过使用双特异性纳米颗粒选择性地将恶性细胞附着到抗原呈递细胞上的新方法。然后,用一系列共振飞秒脉冲照射结合的细胞对,导致广泛的细胞融合和随后形成杂交细胞。金纳米粒子作为连接剂和融合促进剂的双重作用为不同细胞之间的特异性融合提供了一种简单而有效的手段。该技术可用于各种体外和体内应用,这些应用需要在大型异质细胞群体中选择性地融合细胞。